MARKET IS CLOSED
Loading latest tickers...
Market Indices
S&P 500
$7,722.72
+0.73%
NASDAQ 100
$30,807.93
+1.00%
DOW JONES
$51,177.00
+0.49%
NASDAQ Composite
$27,190.86
+1.19%
RUSSELL 2000
$2,815.20
+0.90%
CBOE VIX
$15.31
-6.59%
Sector Heatmap
Technology+1.01%
Financials+0.06%
Healthcare-0.01%
Consumer Cycl+1.13%
Consumer Staples+0.25%
Energy+0.40%
Industrials+0.78%
Materials+0.66%
Real Estate+0.32%
Utilities+0.38%
Comm Services+0.35%
DFTX — Definium Therapeutics, Inc. Common Shares
NasdaqDefinium Therapeutics, Inc. Common Shares
$37.40
-0.20(-0.53%)
- O
- 37.70
- H
- 38.14
- L
- 36.86
- V
- 1.6M
⏱️ End-of-day dataAs of Oct 2, 2026
DFTX — Financial Statements
Historical 2-Year Statements| Financial Metric / Line Item | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 |
|---|---|---|---|---|---|---|
| Fiscal Date | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
| Period | quarterly | quarterly | quarterly | quarterly | quarterly | quarterly |
| Year | 2,026.00 | 2,025.00 | 2,025.00 | 2,025.00 | 2,025.00 | 2,024.00 |
| Cash And Cash Equivalents | 262,518.00 | 257,837.00 | 19,959.00 | 33,392.00 | 82,854.00 | 273,741.00 |
| Other Short Term Investments | 110,904.00 | 153,756.00 | 189,111.00 | 149,601.00 | 129,587.00 | N/A |
| Other Current Assets | 7,141.00 | 7,727.00 | 6,778.00 | 6,143.00 | 9,259.00 | 7,879.00 |
| Total Current Assets | 380,563.00 | 419,320.00 | 215,848.00 | 189,136.00 | 221,700.00 | 281,620.00 |
| Goodwill | 39,836.00 | 39,836.00 | 39,836.00 | 39,836.00 | 39,836.00 | 39,836.00 |
| Other Non Current Assets | 812.00 | 862.00 | 1,150.00 | 1,174.00 | 606.00 | 613.00 |
| Total Non Current Assets | 20,730.00 | 20,780.00 | 21,068.00 | 75,955.00 | 53,623.00 | 20,531.00 |
| Total Assets | 401,293.00 | 440,100.00 | 236,916.00 | 265,091.00 | 275,323.00 | 302,151.00 |
| Accounts Payable | 7,127.00 | 5,347.00 | 8,113.00 | 4,216.00 | 2,268.00 | 2,010.00 |
| Accrued Expenses | 17,101.00 | 10,979.00 | 11,696.00 | 9,616.00 | 7,136.00 | 6,424.00 |
| Pensions | 7,413.00 | 9,467.00 | 7,332.00 | 5,181.00 | 4,361.00 | 6,405.00 |
| Other Current Liabilities | 49,471.00 | 40,905.00 | 38,275.00 | 18,944.00 | 16,716.00 | 24,010.00 |
| Total Current Liabilities | 81,112.00 | 66,698.00 | 65,416.00 | 37,957.00 | 30,481.00 | 38,849.00 |
| Long Term Debt | 40,773.00 | 40,579.00 | 40,385.00 | 41,191.00 | 22,036.00 | 21,854.00 |
| Other Non Current Liabilities | 559.00 | 496.00 | 519.00 | 543.00 | N/A | N/A |
| Total Non Current Liabilities | 41,332.00 | 41,075.00 | 40,904.00 | 41,734.00 | 22,036.00 | 21,854.00 |
| Total Liabilities | 122,444.00 | 107,773.00 | 106,320.00 | 79,691.00 | 52,517.00 | 60,703.00 |
| Common Stock | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Retained Earnings | -659,770.00 | -582,672.00 | -532,236.00 | -464,971.00 | -422,227.00 | -398,879.00 |
| Other Shareholders Equity | 824.00 | 1,085.00 | 1,001.00 | 807.00 | 802.00 | 819.00 |
| Total Shareholders Equity | 278,849.00 | 332,327.00 | 130,596.00 | 185,400.00 | 222,806.00 | 241,448.00 |
| Additional Paid In Capital | 937,795.00 | 913,914.00 | 661,831.00 | 649,564.00 | 644,231.00 | 639,508.00 |
| Investments And Advances | N/A | N/A | N/A | 54,863.00 | 33,099.00 | N/A |